| Gene symbol | ROR1 | Synonyms | NTRKR1, dJ537F10.1 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p31.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | receptor tyrosine kinase like orphan receptor 1 | ||||
| GTO ID | GTC3317 |
| Trial ID | NCT05694364 |
| Disease | Diffuse Large B-Cell Lymphoma | Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Triple-Receptor Negative Breast Cancer | Chronic Lymphocytic Leukemia |
| Altered gene | ROR1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | PRGN-3007 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies |
| Year | 2023 |
| Country | United States |
| Company sponsor | H. Lee Moffitt Cancer Center and Research Institute |
| Other ID(s) | MCC-21622|PRGN-3007 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||
|
|||||||||||